| Clinical Trial of PCV24 in Infants and Children Aged 2 Months to 5 Years (NCT07300644) | Sinovac Life Sciences Co., Ltd. | 2025-11-25 |
| PCV24 Clinical Trial in Infants and Young Children Aged 2 Months (Minimum 6 Weeks) to 71 Months (NCT07333352) | Reinovax Biologics Co., LTD | 2025-09-11 |
| Clinical Trial of PCV24 in Adults Aged ≥18 Years (NCT07543198) | Sinovac Life Sciences Co., Ltd. | 2025-06-18 |
| Clinical Trial of PCV24 in Infants Aged 2-23 Months (NCT06800261) | Sinovac Life Sciences Co., Ltd. | 2025-05-08 |
| Clinical Trial of 13-Valent Pneumococcal Conjugate Vaccine (NCT06617715) | Sinovac Life Sciences Co., Ltd. | 2024-10-23 |
| Clinical Trial of PCV24 in Children Aged 2-17 Years (NCT06550830) | Sinovac Life Sciences Co., Ltd. | 2024-09-07 |
| Clinical Trial of PCV24 in Adults (NCT06474377) | Sinovac Life Sciences Co., Ltd. | 2024-06-21 |
| Phase I Clinical Trial of PCV24 in Children Aged 2 Months (Minimum 6 Weeks) to 17 Years (NCT06675032) | Reinovax Biologics Co., LTD | 2024-04-27 |
| Phase II Clinical Trial of 24-valent Pneumococcal Polysaccharide Conjugate Vaccine (NCT06678620) | Reinovax Biologics Co., LTD | 2024-04-20 |
| A Phase 1b Clinical Trial of 13-valent Pneumococcal Polysaccharide Conjugate Vaccine (NCT06183216) | Sinovac Research and Development Co., Ltd. | 2024-01-04 |
| Phase I Clinical Trial of PCV24 in People Aged 18 Years and Older (NCT06678607) | Reinovax Biologics Co., LTD | 2023-11-19 |
| A Clinical Trial to Observe the Safety of 23-Valent Pneumococcal Polysaccharide Vaccine in Target Population (NCT07071701) | Sinovac Biotech Co., Ltd | 2022-07-02 |